findmyKOL

Daniel Petrylak, MD

Enriched profile

Professor of Medicine (Medical Oncology) and of Urology; Chief, Genitourinary Oncology · Yale School of Medicine

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 New Haven, CT · Northeast · United StatesSpecialtyMedical OncologyFocusProstate Cancer+3
Active KOLfindmyKOL type: EliteLatest publicationNone indexedOnline presenceverified 2026Payments2021–2025NIH funding2018–2022Why? →

Daniel Petrylak is Professor of Medicine (Medical Oncology) and of Urology; Chief, Genitourinary Oncology at Yale School of Medicine. ClinicalTrials.gov lists 10 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Daniel Petrylak, M.D., is Professor of Medicine (Medical Oncology) and of Urology at Yale School of Medicine. The public record shows 13 publications with 3,609 citations (h-index 8), centered on Prostate Cancer, Bladder / Urothelial Cancer, Urethral Neoplasms. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 41 companies, 1 NIH-funded awards (2018–2022).

  • Top research focus: Prostate Cancer
  • 10 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 41 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Prostate Cancer6 trialsBladder / Urothelial Cancer3 trialsUrethral Neoplasms2 trialsUrologic Neoplasms1 trial

Research focus

OpenAlex concept fingerprint
Prostate CancerBladder / Urothelial CancerUrethral NeoplasmsUrologic Neoplasms

Drugs & molecules

across trials, industry payments and publications
Padcevgeneric · EnfortumabClinical trials—Industry payments53Publications—Erleadageneric · ApalutamideClinical trials—Industry payments21Publications—Lynparzageneric · OlaparibClinical trials—Industry payments11Publications—Trodelvygeneric · SacituzumabClinical trials—Industry payments10Publications—Jevtanageneric · CabazitaxelClinical trials—Industry payments9Publications—PiflufolastatClinical trials—Industry payments9Publications—Xtandigeneric · EnzalutamideClinical trials—Industry payments9Publications—Orgovyxgeneric · RelugolixClinical trials—Industry payments6Publications—Talzennageneric · TalazoparibClinical trials—Industry payments6Publications—Cabometyxgeneric · CabozantinibClinical trials—Industry payments5Publications—Balversageneric · ErdafitinibClinical trials—Industry payments4Publications—Keytrudageneric · PembrolizumabClinical trials—Industry payments4Publications—

Works with

trial sponsors and companies reporting payments
Pfizer Inc.Clinical trials—Industry payments29Astellas Pharma Europe LtdClinical trials—Industry payments24Merck Sharp & Dohme LLCClinical trials—Industry payments18Janssen Scientific Affairs, LLCClinical trials—Industry payments17EMD Serono, Inc.Clinical trials—Industry payments16AstraZeneca Pharmaceuticals LPClinical trials—Industry payments14Seagen Inc.Clinical trials—Industry payments14Gilead Sciences, Inc.Clinical trials—Industry payments12Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments11Janssen Biotech, Inc.Clinical trials—Industry payments10Genzyme CorporationClinical trials—Industry payments9Progenics Pharmaceuticals, Inc.Clinical trials—Industry payments9Astellas Pharma US IncClinical trials—Industry payments7Astellas Pharma Global DevelopmentClinical trials—Industry payments6E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments5Exelixis Inc.Clinical trials—Industry payments5Lantheus Medical Imaging, Inc.Clinical trials—Industry payments5Theratechnologies Inc.Clinical trials—Industry payments5ADC Therapeutics America, Inc.Clinical trials—Industry payments3Aveo Pharmaceuticals, Inc.Clinical trials—Industry payments3Merck Sharp & Dohme CorporationClinical trials—Industry payments3SWOG Cancer Research NetworkClinical trials3Industry payments—Blue Earth DiagnosticsClinical trials—Industry payments2Blue Earth Diagnostics LimitedClinical trials—Industry payments2Dendreon Pharmaceuticals LLCClinical trials—Industry payments2Herbert Irving Comprehensive Cancer CenterClinical trials2Industry payments—Janssen Research & Development, LLCClinical trials—Industry payments2Merck KGaAClinical trials—Industry payments2Aadi Bioscience, Inc.Clinical trials—Industry payments1Achieve Life SciencesClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10clinical trials

Investigator role on registered studies.

View trials ↓
41companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2018–2022

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

41 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    67.1%
    Androgen Receptor Inhibitor38.3%
    Xtandi100%
    Part D≥14 patients
    Anti-androgens21.8%
    Nubeqa55%Erleada45%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    28.4%
    Corticosteroid28.4%
    Prednisone100%
    Part D≥13 patients
  • Nervous system

    4.5%
    Opioid Agonist4.5%
    Oxycodone-Acetaminophen100%
    Part D<11 patients
Where care is delivered (Part B)88.7% facility · 11.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

1 NIH research award on record, funded 2018–2022 per NIH RePORTER. The latest:

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/daniel-petrylak-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Other

    medicine.yale.edu/profile/daniel-petrylak

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗

Mentions by others

where others cite or feature them
  • Apple Podcasts

    peer-spectives.podbean.com/e/prostate-cancer-%e2%80%93-daniel-petrylak-md-and-robert-figlin-md-discuss-recent-clinical-advances-in-prostate-cancer-from-asco-gu

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →peer-spectives.podbean.com ↗
  • Other

    grandroundsinurology.com/author/dpetrylak/page/2

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Other

    ynhhs.org/physicians/daniel-p-petrylak

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ynhhs.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Case Western Reserve University School of Medicine

    1985
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Board Certified

    Medical Oncology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connect.medicalnewstoday.com ↗

Editorial & leadership roles

journal and society appointments
  • Medical Advisory Board

    Tyme Technologies

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biospace.com ↗
  • Program Committee

    American Urological Association

    2011
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Chairman

    Scientific Advisory Board, Egenix

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biospace.com ↗
  • Program Committee

    American Society of Clinical Oncology

    2003
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Vice Chair

    Genitourinary Committee, Southwest Oncology Group (SWOG)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Advanced Bladder Chair

    Southwest Oncology Group (SWOG), 20+ years

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Committee Member

    FDA Devices and Immunologicals section

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Member

    American Association for Cancer Research (AACR)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Member

    American Society of Clinical Oncology (ASCO)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Member

    American College of Physicians (ACP)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗
  • Member

    American Urological Association (AUA)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grandroundsinurology.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.